MicroRNA 548ag-2 (MIR548AG2)

MicroRNA 548ag-2 (MIR548AG2) is a member of the mir-548 microRNA family, which encodes a small non-coding RNA molecule involved in post-transcriptional gene silencing. Like other microRNAs, MIR548AG2 is transcribed as a primary transcript, processed in the nucleus and cytoplasm to yield a 20–24 nucleotide mature miRNA. This mature miRNA is incorporated into the RNA-induced silencing complex (RISC). There, through imperfect base-pairing with target mRNAs, MIR548AG2 predominantly leads to translational inhibition or destabilization of its mRNA targets. The function of miR-548ag-2 as an oncogene has been demonstrated in the context of obesity-related endometrial cancer, where it suppresses MOB1B, thereby promoting malignancy[1]. As for many specific microRNAs, detailed roles in disease outside preliminary cancer research remain largely unexplored, and there are currently no known approved or experimental drugs that directly target MIR548AG2, nor is it established as a biomarker or listed with known safety risks[1][2][3][6]. MicroRNAs, including MIR548AG2, are classified as non-coding regulatory RNAs, not as traditional "therapeutic targets" such as receptors, enzymes, or ion channels. Their disease roles and therapeutic targeting are under investigation, but direct targeting is not established in clinical practice at this time[1][6]. Nomenclature resources and human gene databases consistently use "MicroRNA 548ag-2" (abbreviation "MIR548AG2") as the standardized name and identifier, with "hsa-mir-548ag-2" reflecting the human species ("hsa" for Homo sapiens)[1][6]. The mir-548 family is specific to primates and is thought to play roles in cancer biology, but most members are not fully characterized with respect to their biological or disease functions[1][6].

Other names

hsa-mir-548ag-2MIR548AG2